SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001600620-24-000093
Filing Date
2024-08-08
Accepted
2024-08-08 16:06:59
Documents
1
Period of Report
2024-08-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1723147608.html 4  
1 FORM 4 wk-form4_1723147608.xml 4 3813
  Complete submission text file 0001600620-24-000093.txt   5199
Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

IRS No.: 981231763 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address #1203-4464 MARKHAM STREET VICTORIA A1 V8Z7X8
Business Address
Habig Scott Michael (Reporting) CIK: 0001938159 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36421 | Film No.: 241188251